A Nomogram for Predicting Metachronous Gastric Cancer After Endoscopic Submucosal Dissection of Early Gastric Cancer Following Successful Eradication.
[PURPOSE] Due to the preservation of the entire stomach after endoscopic resection, the occurrence of metachronous gastric cancer (MGC) remains a possibility.
- 추적기간 41.5 months
APA
Mao S, Liu M, et al. (2026). A Nomogram for Predicting Metachronous Gastric Cancer After Endoscopic Submucosal Dissection of Early Gastric Cancer Following Successful Eradication.. Journal of gastric cancer, 26(2), 279-294. https://doi.org/10.5230/jgc.2026.26.e21
MLA
Mao S, et al.. "A Nomogram for Predicting Metachronous Gastric Cancer After Endoscopic Submucosal Dissection of Early Gastric Cancer Following Successful Eradication.." Journal of gastric cancer, vol. 26, no. 2, 2026, pp. 279-294.
PMID
41942360
Abstract
[PURPOSE] Due to the preservation of the entire stomach after endoscopic resection, the occurrence of metachronous gastric cancer (MGC) remains a possibility. In this study, we investigated the incidence and risk factors for MGC in patients with early gastric cancer who underwent endoscopic submucosal dissection (ESD) and successfully eradicated .
[MATERIALS AND METHODS] A retrospective analysis was conducted of 1,191 patients who underwent ESD and successfully eradicated at the Affiliated Drum Tower Hospital of Nanjing University. Endoscopic surveillance was performed at 3, 6, and 12 months post-resection, and annually thereafter. MGC was defined as the development of a new cancer at a site other than the primary gastric cancer site, at least 1 year after the initial endoscopic resection.
[RESULTS] A total of 77 patients were diagnosed with MGC during a median follow-up of 41.5 months. Kaplan-Meier analysis showed a 5-year cumulative incidence of MGC of 9.4% after successful eradication. Multivariate analysis of the training set using Cox proportional hazards models identified male sex, severe atrophic gastritis, multiple gastric cancers before eradication, and smoking history as independent risk factors for MGC. The nomogram exhibited favorable discrimination, with area under the curves of 0.767 and 0.822 in the training set and 0.724 and 0.745 in the testing set at 3 and 5 years, respectively.
[CONCLUSIONS] Patients with gastric cancer who undergo endoscopic resection, even after successful eradication, should undergo annual and continuous endoscopic surveillance for MGC.
[MATERIALS AND METHODS] A retrospective analysis was conducted of 1,191 patients who underwent ESD and successfully eradicated at the Affiliated Drum Tower Hospital of Nanjing University. Endoscopic surveillance was performed at 3, 6, and 12 months post-resection, and annually thereafter. MGC was defined as the development of a new cancer at a site other than the primary gastric cancer site, at least 1 year after the initial endoscopic resection.
[RESULTS] A total of 77 patients were diagnosed with MGC during a median follow-up of 41.5 months. Kaplan-Meier analysis showed a 5-year cumulative incidence of MGC of 9.4% after successful eradication. Multivariate analysis of the training set using Cox proportional hazards models identified male sex, severe atrophic gastritis, multiple gastric cancers before eradication, and smoking history as independent risk factors for MGC. The nomogram exhibited favorable discrimination, with area under the curves of 0.767 and 0.822 in the training set and 0.724 and 0.745 in the testing set at 3 and 5 years, respectively.
[CONCLUSIONS] Patients with gastric cancer who undergo endoscopic resection, even after successful eradication, should undergo annual and continuous endoscopic surveillance for MGC.
MeSH Terms
Humans; Stomach Neoplasms; Male; Endoscopic Mucosal Resection; Female; Helicobacter Infections; Middle Aged; Retrospective Studies; Helicobacter pylori; Neoplasms, Second Primary; Nomograms; Aged; Risk Factors; Incidence; Gastroscopy; Follow-Up Studies
같은 제1저자의 인용 많은 논문 (5)
- The double-edged sword of pyroptosis targeting in cancer therapy.
- Bacterial skin colonization and systemic antibiotic treatment in patients with cutaneous T-cell lymphoma.
- Loss of cyclin C drives resistance to anti-TIGIT therapy by upregulating CD155-mediated immune evasion.
- Integration of clinical, pathological, and endoscopic data improves prediction for lymph node metastasis in early gastric cancer: a retrospective multicenter study.
- Ultrasensitive biosensing platform via self-catalytic-induced luminescence amplification and bifunctional biopeptides for immunoassay.